Literature DB >> 3390137

Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts.

J P Slotte1, E L Bierman.   

Abstract

This study examines the relationship between cellular sphingomyelin content and the distribution of unesterified cholesterol between the plasma-membrane pool and the putative intracellular regulatory pool. The sphingomyelin content of cultured human skin fibroblasts was reduced by treatment of intact cells with extracellularly added neutral sphingomyelinase, and subsequent changes in the activities of cholesterol-metabolizing enzymes were determined. Exposure of fibroblasts to 0.1 unit of sphingomyelinase/ml for 60 min led to the depletion of more than 90% of the cellular sphingomyelin, as determined from total lipid extracts. In a time-course study, it was found that within 10 min of the addition of sphingomyelinase to cells, a dramatic increase in acyl-CoA:cholesterol acyltransferase activity could be observed, whether measured from the appearance of plasma membrane-derived [3H]cholesterol or exogenously added [14C]oleic acid, in cellular cholesteryl esters. In addition, the cholesteryl ester mass was significantly higher in sphingomyelin-depleted fibroblasts at 3 h after exposure to sphingomyelinase compared with that in untreated fibroblasts [7.1 +/- 0.4 nmol of cholesterol/mg equivalents of esterified cholesterol compared with 4.2 +/- 0.1 nmol of cholesterol/mg equivalents of cholesteryl ester in control cells (P less than 0.05)]. The sphingomyelin-depleted cells also showed a reduction in the rate of endogenous synthesis of cholesterol, as measured by incorporation of sodium [14C]acetate into [14C]cholesterol. These results are consistent with a rapid movement of cholesterol from sphingomyelin-depleted plasma membranes to the putative intracellular regulatory pool of cholesterol. This mass movement of cholesterol away from the plasma membranes presumably resulted from a decreased capacity of the plasma membranes to solubilize cholesterol, since sphingomyelin-depleted cells also had a decreased capacity to incorporate nanomolar amounts of [3H]cholesterol from the extracellular medium, as compared with control cells. These findings confirm previous assumptions that the membrane sphingomyelin content is an important determinant of the overall distribution of cholesterol within intact cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390137      PMCID: PMC1148908          DOI: 10.1042/bj2500653

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Complete exchangeability of cholesterol in phosphatidylcholine/cholesterol vesicles of different degrees of unsaturation.

Authors:  B Bloj; D B Zilversmit
Journal:  Biochemistry       Date:  1977-09-06       Impact factor: 3.162

3.  Phospholipid class and fatty acid composition of golgi apparatus isolated from rat liver and comparison with other cell fractions.

Authors:  T W Keenan; D J Morré
Journal:  Biochemistry       Date:  1970-01-06       Impact factor: 3.162

4.  Quantitative analysis of phospholipids by thin-layer chromatography.

Authors:  V P Skipski; R F Peterson; M Barclay
Journal:  Biochem J       Date:  1964-02       Impact factor: 3.857

5.  The properties of polyunsaturated lecithins in monolayers and liposomes and the interactions of these lecithins with cholesterol.

Authors:  R A Demiel; W S Guerts van Kessel; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1972-04-14

6.  Enzymic characterization and lipid composition of rat liver subcellular membranes.

Authors:  A Colbeau; J Nachbaur; P M Vignais
Journal:  Biochim Biophys Acta       Date:  1971-12-03

7.  Increased cholesterol-ester formation during forced cholesterol synthesis in rat hepatocytes.

Authors:  A Nilsson
Journal:  Eur J Biochem       Date:  1975-02-21

8.  Isolation and characterization of subcellular membranes with altered phospholipid composition from cultured fibroblasts.

Authors:  F Schroeder; J F Perlmutter; M Glaser; P R Vagelos
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

9.  Lipid composition and protein profiles of outer and inner membranes from pig heart mitochondria. Comparison with microsomes.

Authors:  J Comte; B Maïsterrena; D C Gautheron
Journal:  Biochim Biophys Acta       Date:  1976-01-21

10.  The preferential interaction of cholesterol with different classes of phospholipids.

Authors:  R A Demel; J W Jansen; P W van Dijck; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1977-02-14
View more
  75 in total

Review 1.  Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease.

Authors:  W G Wood; F Schroeder; N A Avdulov; S V Chochina; U Igbavboa
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

2.  Resistance of cell membranes to different detergents.

Authors:  Sebastian Schuck; Masanori Honsho; Kim Ekroos; Andrej Shevchenko; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

3.  Sphingomyelin depletion in cultured cells blocks proteolysis of sterol regulatory element binding proteins at site 1.

Authors:  S Scheek; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Protection of membrane cholesterol by sphingomyelin against free radical-mediated oxidation.

Authors:  Robert M Sargis; Papasani V Subbaiah
Journal:  Free Radic Biol Med       Date:  2006-02-28       Impact factor: 7.376

5.  Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins.

Authors:  Philippe Marmillot; Sanket Patel; M Raj Lakshman
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

6.  Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans.

Authors:  Philippe Marmillot; Jennifer Munoz; Sanket Patel; Mamatha Garige; Richard B Rosse; M Raj Lakshman
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

7.  GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.

Authors:  Hao Li; Stephen D Turley; Benny Liu; Joyce J Repa; John M Dietschy
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

8.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

9.  Localization of cholesterol in sphingomyelinase-treated fibroblasts.

Authors:  M I Pörn; J P Slotte
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

10.  Differential effects of membrane sphingomyelin and cholesterol on agonist-induced bitter taste receptor T2R14 signaling.

Authors:  Feroz Ahmed Shaik; Prashen Chelikani
Journal:  Mol Cell Biochem       Date:  2019-09-20       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.